Diversion Control Division, US Department of Justice, Drug Enforcement Administration

RESOURCES > Federal Register Notices > Manufacturers Notice of Registration - 2017 > Bulk Manufacturer of Controlled Substances Registration

Manufacturers Notice of Registration - 2017

[Federal Register Volume 82, Number 55 (Thursday, March 23, 2017)]
[Notices]
[Page 14913]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-05727]


DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-392]

Bulk Manufacturer of Controlled Substances Registration

ACTION: Notice of registration.


SUMMARY: Registrants listed below have applied for and been granted registration by the Drug Enforcement Administration (DEA) as bulk manufacturers of various classes of controlled substances.

SUPPLEMENTARY INFORMATION: The companies listed below applied to be registered as manufacturers of various basic classes of controlled substances. Information on previously published notices is listed in the table below. No comments or objections were submitted for these notices.

Company FR Docket Published
Noramco, Inc. 81 FR 57936 August 24, 2016
Isosciences 81 FR 61249 September 6, 2016
AMRI Rensselaer, Inc. 81 FR 61250 September 6, 2016
Halo Pharmaceutical, Inc. 81 FR 63220 September 14, 2016
AMPAC Fine Chemicals LLC 81 FR 63222 September 14, 2016
Insys Manufacturing LLC 81 FR 63221 September 14, 2016
Patheon API Manufacturing, Inc. 81 FR 64509 September 20, 2016
Euticals Inc. 81 FR 64510 September 20, 2016
Nanosyn, Inc. 81 FR 64949 September 21, 2016
Cerilliant Corporation 81 FR 66079 September 26, 2016
Research Triangle Institute 81 FR 91948 December 19, 2016
Synthcon LLC 81 FR 95641 December 28, 2016
Navinta LLC 81 FR 95640 December 28, 2016
Johnson Matthey, Inc. 81 FR 95647 December 28, 2016
AMRI Rensselaer, Inc. 81 FR 95639 December 28, 2016
Cayman Chemical Company 81 FR 95644 December 28, 2016
Cambridge Isotope Laboratories 81 FR 95644 December 28, 2016
Janssen Pharmaceutical, Inc. 81 FR 96045 December 29, 2016

The DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of these registrants to manufacture the applicable basic classes of controlled substances is consistent with the public interest and with United States obligations under international treaties, conventions, or protocols in effect on May 1, 1971. The DEA investigated each of the company's maintenance of effective controls against diversion by inspecting and testing each company's physical security systems, verifying each company's compliance with state and local laws, and reviewing each company's background and history.

Therefore, pursuant to 21 U.S.C. 823(a), and in accordance with 21 CFR 1301.33, the DEA has granted a registration as a bulk manufacturer to the above listed persons.

Dated: March 17, 2017.

Louis J. Milione,
Assistant Administrator.

[FR Doc. 2017-05727 Filed 3-22-17; 8:45 am]

BILLING CODE 4410-09-P

NOTICE: This is an unofficial version. An official version of this publication may be obtained directly from the Government Publishing Office (GPO).

Emergency Disaster Relief
National Prescription Drug Take Back Day. Turn in your unused or expired medication for safe disposal here.
RX Abuse Online

U.S. DEPARTMENT OF JUSTICE  •  DRUG ENFORCEMENT ADMINISTRATION
Diversion Control Division  •  8701 Morrissette Drive  •  Springfield, VA 22152  •  1-800-882-9539

DOJ Legal Policies and Disclaimers    |    DOJ Privacy Policy    |    FOIA    |    Section 508 Accessibility